Cardiovascular and Renal Outcomes in Type 2 Diabetes Medications with Dr. Marie McDonnell

 
Share
 

Manage episode 241459392 series 2295711
By NEJM Resident 360 and NEJM Group. Discovered by Player FM and our community — copyright is owned by the publisher, not Player FM, and audio is streamed directly from their servers. Hit the Subscribe button to track updates in Player FM, or paste the feed URL into other podcast apps.
The number of medications available to treat diabetes continues to increase. Recently, there has been widespread interest in two classes of medications, the SGLT2 inhibitors and the GLP1 agonists. They have created quite the splash with improvements in cardiovascular outcomes in patients with type 2 diabetes. In this podcast...

56 episodes